Find information on how we’re keeping you safe from COVID-19 here
Areas of Expertise
- Immunochemistry (diagnostic and therapy-related)
Professor Andrew Nicholson is a consultant histopathologist specialising in thoracic pathology, and an honorary professor of respiratory pathology at the National Heart and Lung Institute, Imperial College London. He has particular expertise in thoracic pathology (lung and mediastinum) and conducts research into lung cancer and interstitial lung disease in particular. He reports between 200 and 300 referrals from clinicians and other pathologists, nationally and internationally, each year.
Professor Nicholson lectures regularly at regional, national and international levels. He has spoken extensively in Europe, Asia, North and South America, and Australia, both as a guest speaker at international conferences and as a stand-alone teacher at specific lung pathology courses. He also organises a practical lung pathology course each year, which attracts attendees from around the globe.
He is the former chair of the International Association for the Study of Lung Cancer (IASLC) committee for the classification of lung tumours, as well as a member of the IASLC Staging and Prognostic Factors Committee.
Research and Publications
- Corrin B and Nicholson AG. Pathology of the Lungs, 2nd Ed. Elsevier, Edinburgh. 2006 and 3rd Ed. Elsevier, Edinburgh. 2011.
- Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: International Agency for Research on Cancer; 2015. Editor ofr 2020 Edition.
- Travis WD Nicholson AG, Geisinger KR, Brambilla E. Atlas of Tumor Pathology. Series Editor S. Sternberg. Tumors of the Lower Respiratory Tract. 2019.
- Andrew G Nicholson, Alain C Borzcuk, Aliya Husain. Tumors of the Serosal Membranes. Written. Due for publication in 2021.
5. Nicholson AG et al. Dataset for reporting of Thymic Epithelial Tumours: Recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2017;70:522-538.
6. Husain AN et al. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2018;142:89-108.
7. Raghu G et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198:e44-e68.
8. Yatabe Y et al. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer. J Thorac Oncol. 2019;14:377-407.
9. Nicholson AG et al.. EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach. J Thorac Oncol. 2020;15:29-49.
10. Raghu G et al. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;1;202:e36-e69.
Why did you choose to become a part of OneWelbeck?
To be part of a world class team of doctors providing care for respiratory disease
What are the moments which stand out most in your career so far?
(1) Receiving a lifetime achievement award for Lung Cancer Research.
(2) Being asked to be an editor by the World Health Organisation for classification of thoracic tumours.
What keeps you busy in your personal life?
Sport (cricket, golf, squash) and creative writing.